tromethamine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azenha Rama, T; Cernadas, J; Moço Coutinho, R; Moreira, A; Mota, D | 1 |
| Davila-Fernandez, G; Madrigal-Burgaleta, R; Sanchez-Moreno, GV | 1 |
| Belay, C; Cherry, L; Diamant, E; Hindi, A; Madmon, M; Mimran, A; Ophir, Y; Pitel, S; Segula, Y; Shamai Yamin, T; Toister, E; Weissberg, A; Zichel, R | 1 |
3 other study(ies) available for tromethamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Hypersensitivity to the Moderna COVID-19 Vaccine Caused by Tromethamine: PEG Is Not Always the Culprit Excipient.
Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; Excipients; Humans; Hypersensitivity; Tromethamine | 2022 |
Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2.
Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Tromethamine; Vaccines, Inactivated | 2022 |
Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; COVID-19; COVID-19 Vaccines; Drug Compounding; Humans; SARS-CoV-2; Tandem Mass Spectrometry; Tromethamine | 2022 |